# Commission Decision of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under document number C(2002) 1344) (Text with EEA relevance) (2002/364/EC), Division 3.1.5

Extent: E+W+S+N.I.

If discrepant test results are identified as part of an evaluation, these results shall be resolved as far as possible, for example:
by evaluation of the discrepant sample in further test systems,
by use of an alternative method or marker,
by a review of the clinical status and diagnosis of the patient, and
by the testing of follow-up-samples.

---
Source: https://www.legislation.gov.uk/eudn/2002/364/annex/division/3/division/3.1/division/1/division/3.1.5 (the official version)
Page: https://openlegislation.uk/eu-decision-2002-364/annex/division-3/division-3.1/division-1/division-3.1.5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.